Richard E. Uihlein
CIK: 0001694903
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALECTIN THERAPEUTICS INC
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 31, 2026GALT
GALECTIN THERAPEUTICS INC
Exercise(M)Indirect31.8M shares at avg. $3.00$95.5M - Jul 31, 2026GALT
GALECTIN THERAPEUTICS INC
Exercise(M)Indirect2.6M shares at avg. $4.05$10.3M - Jan 16, 2026GALT
GALECTIN THERAPEUTICS INC
Award(A)Direct13.2K shares at avg. $3.04$40K - Jan 23, 2025GALT
GALECTIN THERAPEUTICS INC
Award(A)Direct32.5K shares at avg. $1.23$40K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | GALT GALECTIN THERAPEUTICS INC | Exercise(M) | 31,825,235 | $3.00 | $95,475,705 | Indirect |
| Jul 31, 2026 | GALT GALECTIN THERAPEUTICS INC | Exercise(M) | 2,550,932 | $4.05 | $10,331,275 | Indirect |
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | Award(A) | 13,158 | $3.04 | $40,000 | Direct |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Award(A) | 32,520 | $1.23 | $40,000 | Direct |
1-4 of 4 transactions
About Uihlein Richard E
Uihlein Richard E (SEC CIK 0001694903) files insider reports with the SEC as Director of GALECTIN THERAPEUTICS INC (GALT).
Signal8 holds 3 ownership filings by Uihlein Richard E, all Form 4s, filed between Jan 27, 2025 and Aug 4, 2026. Those filings report 4 transactions, from Jan 23, 2025 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Uihlein Richard E's filings is in NORCROSS, GA.
Recent filings by Uihlein Richard E
Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)
- Jamil Khurram, Chief Medical Officer
- Shlevin Harold H., Director
- Brem Henry, Director
- ELDRED KARY, Director
- LEWIS JOEL, President and CEO
- CARSON BENJAMIN SR, Director